Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
United States Oil Fund LP
USO
US Stock MarketDetailed Quotes
Lexicon Pharmaceuticals (LXRX)
- 2.340
- -0.010-0.43%
Close Aug 13 15:59 ET
1.04BMarket Cap-14.63P/E (TTM)
2.390High2.320Low2.32MVolume2.370Open2.350Prev Close5.47MTurnover0.89%Turnover RatioLossP/E (Static)444.96MShares2.68052wk High5.97P/B609.50MFloat Cap1.03052wk Low--Dividend TTM260.47MShs Float344.750Historical High--Div Yield TTM2.98%Range %0.284Historical Low2.361Avg Price1Lot Size
About Lexicon Pharmaceuticals Company
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Company Profile
SymbolLXRX
Company NameLexicon Pharmaceuticals
Listing DateApr 7, 2000
Issue Price22.00
ISINUS5288723027
Founded1995
CEODr. Michael Exton, PhD
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address2445 Technology Forest Boulevard,11th floor
CityThe Woodlands
ProvinceTexas
CountryUnited States of America
Zip Code77381-1160
Phone1-281-863-3000
Websitehttp://www.lexpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Michael Exton, PhD
- Chief Executive Officer and Director
- 3.55M
- Scott M. Coiante
- Senior Vice President and Chief Financial Officer
- 1.56M
- Dr. Craig B. Granowitz, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.76M
- Kristen L. Alexander
- Vice President, Finance and Accounting and Principal Accounting Officer
- --
- Wendy E. McDermott
- Senior Vice President, Human Resources
- 1.27M
- Suma Gopinathan, M.S.,PhD
- Senior Vice President, Discovery
- --
- Rachel Yap Martens
- Senior Vice President, Partnerships and Corporate Strategy
- --
- Lisa DeFrancesco
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Brian T. Crum
- Senior Vice President and General Counsel
- 1.50M
- Raymond Debbane
- Chairman of the Board
- 196.33K
- Diane E. Sullivan
- Independent Director
- 171.33K
- Philippe J. Amouyal
- Independent Director
- 176.33K
- Ivan H. Cheung
- Independent Director
- 171.33K
- Christopher J. Sobecki
- Independent Director
- 161.33K
- Dr. Samuel L. Barker,PhD
- Independent Director
- 188.83K
- Dr. Judith L. Swain,M.D.
- Independent Director
- 173.83K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm